Nasopharyngeal carcinoma medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 5: | Line 5: | ||
The mainstay of therapy for nasopharyngeal carcinoma is external beam [[radiotherapy]], supplemented in some cases with [[chemotherapy]]. | The mainstay of therapy for nasopharyngeal carcinoma is external beam [[radiotherapy]], supplemented in some cases with [[chemotherapy]]. | ||
==Medical Therapy== | ==Medical Therapy== | ||
*Standard treatments for patients with nasopharyngeal carcinoma include:<ref>http://www.cancer.gov/types/head-and-neck/hp/nasopharyngeal-treatment-pdq#section/_50</ref> | |||
*Standard treatments for patients with nasopharyngeal carcinoma include: | |||
**Radiation therapy alone | **Radiation therapy alone | ||
**Concurrent | **Concurrent chemoradiation followed by adjuvant chemotherapy | ||
**Chemotherapy alone for | **Chemotherapy alone for [[metastatic]] disease | ||
*Treatments under clinical evaluation for patients with [[nasopharyngeal cancer]] include the following:<ref name="pmid10571198">{{cite journal| author=Tate DJ, Adler JR, Chang SD, Marquez S, Eulau SM, Fee WE et al.| title=Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinoma: impact on local control. | journal=Int J Radiat Oncol Biol Phys | year= 1999 | volume= 45 | issue= 4 | pages= 915-21 | pmid=10571198 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10571198 }} </ref> | |||
*Treatments under clinical evaluation for patients with nasopharyngeal cancer include the following: | |||
**Dose escalation with new radiation therapy techniques such as stereotactic radiation therapy boost | **Dose escalation with new radiation therapy techniques such as stereotactic radiation therapy boost | ||
**[[Brachytherapy]] | |||
**Brachytherapy | |||
Undifferentiated subtype of NPC is highly radiosensitive.<ref name="Weidner's">{{cite book |author=Richard Cote, Saul Suster, Lawrence Weiss, Noel Weidner (Editor) |title=Modern Surgical Pathology (2 Volume Set) |publisher=W B Saunders |location=London |year= |pages= |isbn=0-7216-7253-1 |oclc= |doi=}</ref> | Undifferentiated subtype of NPC is highly radiosensitive.<ref name="Weidner's">{{cite book |author=Richard Cote, Saul Suster, Lawrence Weiss, Noel Weidner (Editor) |title=Modern Surgical Pathology (2 Volume Set) |publisher=W B Saunders |location=London |year= |pages= |isbn=0-7216-7253-1 |oclc= |doi=}</ref> | ||
Revision as of 18:22, 16 September 2015
Nasopharyngeal carcinoma Microchapters |
Differentiating Nasopharyngeal carcinoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Nasopharyngeal carcinoma medical therapy On the Web |
American Roentgen Ray Society Images of Nasopharyngeal carcinoma medical therapy |
Risk calculators and risk factors for Nasopharyngeal carcinoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]
Overview
The mainstay of therapy for nasopharyngeal carcinoma is external beam radiotherapy, supplemented in some cases with chemotherapy.
Medical Therapy
- Standard treatments for patients with nasopharyngeal carcinoma include:[1]
- Radiation therapy alone
- Concurrent chemoradiation followed by adjuvant chemotherapy
- Chemotherapy alone for metastatic disease
- Treatments under clinical evaluation for patients with nasopharyngeal cancer include the following:[2]
- Dose escalation with new radiation therapy techniques such as stereotactic radiation therapy boost
- Brachytherapy
Undifferentiated subtype of NPC is highly radiosensitive.[3]
References
- ↑ http://www.cancer.gov/types/head-and-neck/hp/nasopharyngeal-treatment-pdq#section/_50
- ↑ Tate DJ, Adler JR, Chang SD, Marquez S, Eulau SM, Fee WE; et al. (1999). "Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinoma: impact on local control". Int J Radiat Oncol Biol Phys. 45 (4): 915–21. PMID 10571198.
- ↑ {{cite book |author=Richard Cote, Saul Suster, Lawrence Weiss, Noel Weidner (Editor) |title=Modern Surgical Pathology (2 Volume Set) |publisher=W B Saunders |location=London |year= |pages= |isbn=0-7216-7253-1 |oclc= |doi=}